Journal of Medicinal Chemistry · 2003 · 122 citations · 20 references
PharmacyMedicinal ChemistryPharmacologyDrug DiscoveryMolecular PharmacologyStructure-activity RelationshipsEnzyme InhibitionLigand BindingStructure-activity Relationship AnalysisActive Site AnalysisActive Site CharacterizationAmino Acid ProfilingAntibody Cross-reactivityAntimalarial AgentsAntimalarial Drug DevelopmentCdk InhibitorsPlasmodium Falciparum
Cyclin dependent protein kinases (CDKs) have become attractive drug targets in an effort to identify effective inhibitors of the parasite Plasmodium falciparum, the causative agent of the most severe form of human malaria. We tested known CDK inhibitors for their ability to inhibit two malarial CDKs: Pfmrk and PfPK5. Many broad spectrum CDK inhibitors failed to inhibit Pfmrk suggesting that the active site differs from other CDKs in important ways. By screening compounds in the Walter Reed chemical database, we identified oxindole-based compounds as effective inhibitors of Pfmrk (IC(50) = 1.5 microM). These compounds have low cross-reactivity against PfPK5 and human CDK1 demonstrating selectivity for Pfmrk. Amino acid comparison of the active sites of Pfmrk and PfPK5 identified unique amino acid differences that may explain this selectivity and be exploited for further drug development efforts.
20
Human Malaria Parasites in Continuous Culture
William Trager, James B. Jensen · Science · 1976 · 8K citations
Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex
Philip D. Jeffrey, Alicia A. Russo, Kornélia Polyák et al. · Nature · 1995 · 1.4K citations
Inhibition of Cyclin‐Dependent Kinases by Purine Analogues
Jaroslav Veselý, Libor Havlı́ček, Miroslav Strnad et al. · European Journal of Biochemistry · 1994 · 626 citations · Full text